Show simple item record

dc.contributor.authorTaylor, James M.en
dc.contributor.authorDunkerley, Sarahen
dc.contributor.authorSilver, David A.en
dc.contributor.authorRedfern, Andrewen
dc.contributor.authorTalbot, Nick J.en
dc.contributor.authorSharpe, Ian T.en
dc.contributor.authorGuyver, Paul M.en
dc.date.accessioned2016-02-08T15:42:26Zen
dc.date.available2016-02-08T15:42:26Zen
dc.date.issued2016-03en
dc.identifier.citationExtracorporeal shockwave therapy (ESWT) for refractory Achilles tendinopathy: A prospective audit with 2-year follow up. 2016, 26:23-29 Foot (Edinb)en
dc.identifier.issn1532-2963en
dc.identifier.pmid26802946en
dc.identifier.doi10.1016/j.foot.2015.08.007en
dc.identifier.urihttp://hdl.handle.net/11287/595884en
dc.description.abstractAchilles tendinopathy (AT) represents a triad of tendon pain, swelling and impaired performance. Extracorporeal shockwave therapy (ESWT) has been endorsed by the National Institute for Health and Care Excellence (NICE) for refractory AT. This audit investigates the long-term outcomes of patients treated with ESWT for refractory AT.en
dc.languageENGen
dc.language.isoenen
dc.publisherElsevieren
dc.relation.urlhttp://www.sciencedirect.com/science/article/pii/S095825921500084Xen
dc.rightsArchived with thanks to Foot (Edinburgh, Scotland)en
dc.subjectWessex Classification Subject Headings::Orthopaedicsen
dc.titleExtracorporeal shockwave therapy (ESWT) for refractory Achilles tendinopathy: A prospective audit with 2-year follow up.en
dc.typeJournal Articleen
dc.identifier.journalFoot (Edinburgh, Scotland)en
dc.type.versionPublisheden
dc.description.admin-noteAccepted manuscript, 12 month embargo, CC-BY-NC-NDen


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record